Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000514297 | SCV000610239 | uncertain significance | not provided | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316460 | SCV000849952 | benign | Inborn genetic diseases | 2019-07-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000514297 | SCV001155415 | likely benign | not provided | 2018-03-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514297 | SCV001845350 | benign | not provided | 2020-02-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000514297 | SCV002145921 | likely benign | not provided | 2024-01-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003962418 | SCV004782374 | likely benign | KAT6A-related disorder | 2021-09-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |